文献速递遗传性与小管间质肾病急性肾损伤

急性肾小管间质性肾炎的全基因组关联研究

Genome-Wide Association Study in Acute Tubulointerstitial Nephritis.
PubMed 文献 · J Am Soc Nephrol · 2023-02-02

该研究首次对544例经肾活检确诊的急性肾小管间质性肾炎(ATIN)患者和2346例中国血统对照者进行两阶段全基因组关联研究及荟萃分析,发现HLA-DQA1区域rs35087390和PLEKHA5基因rs2417771两个全基因组显著位点,HLA-DRB1*14主要驱动HLA风险关联,HLA风险基因型与疾病严重程度及免疫抑制治疗反应相关。

要点

  • 首次ATIN全基因组关联研究识别HLA-DQA1 rs35087390(P=3.01×10^-39)和PLEKHA5 rs2417771(P=2.14×10^-8)两个显著位点。
  • HLA-DRB1*14主要驱动HLA风险关联,HLA-DRB1第60位氨基酸(P10口袋)为关键位点。
  • 不同临床亚型(药物相关或肾小管间质性肾炎-葡萄膜炎综合征)似乎共享相同风险等位基因。

核心结论

  • 研究识别出两个与ATIN易感性相关的候选基因组区域,提示遗传决定的免疫调节异常风险参与ATIN发病机制。

研究设计与样本

  • 首次两阶段全基因组关联研究及荟萃分析,纳入544例经肾活检定义的ATIN患者和2346例中国血统对照者。

主要发现

  • HLA-DQA1 rs35087390(P=3.01×10^-39)和PLEKHA5 rs2417771(P=2.14×10^-8)为两个全基因组显著位点。
  • HLA-DRB1*14主要驱动HLA风险关联,HLA-DRB1第60位氨基酸(P10口袋)为关键氨基酸位点。
  • 包含与不包含HLA位点的SNP遗传力估计分别为20.43%和10.35%。
  • 不同临床亚型(药物相关或肾小管间质性肾炎-葡萄膜炎综合征)似乎共享相同风险等位基因。
  • HLA风险基因型与疾病严重程度及免疫抑制治疗反应率相关。

关键数值与推荐

  • 风险单倍型DRB1*14-DQA1*0101-DQB1*0503(DR14血清型),保护单倍型DRB1*1501-DQA1*0102-DQB1*0602(DR15血清型)。
  • HLA-DQA1 rs35087390的P=3.01×10^-39,PLEKHA5 rs2417771的P=2.14×10^-8。
  • 包含HLA位点的SNP遗传力为20.43%,不包含HLA位点为10.35%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SIGNIFICANCE STATEMENT: Polymorphisms of HLA genes may confer susceptibility to acute tubulointerstitial nephritis (ATIN), but small sample sizes and candidate gene design have hindered their investigation. The first genome-wide association study of ATIN identified two significant loci, risk haplotype DRB1*14-DQA1*0101-DQB1*0503 (DR14 serotype) and protective haplotype DRB1*1501-DQA1*0102-DQB1*0602 (DR15 serotype), with amino acid position 60 in the peptide-binding groove P10 of HLA-DR β 1 key. Risk alleles were shared among different causes of ATIN and HLA genotypes associated with kidney injury and immune therapy response. HLA alleles showed the strongest association. The findings suggest that a genetically conferred risk of immune dysregulation is part of the pathogenesis of ATIN. BACKGROUND: Acute tubulointerstitial nephritis (ATIN) is a rare immune-related disease, accounting for approximately 10% of patients with unexplained AKI. Previous elucidation of the relationship between genetic factors that contribute to its pathogenesis was hampered because of small sample sizes and candidate gene design. METHODS: We undertook the first two-stage genome-wide association study and meta-analysis involving 544 kidney biopsy-defined patients with ATIN and 2346 controls of Chinese ancestry. We conducted statistical fine-mapping analysis, provided functional annotations of significant variants, estimated single nucleotide polymorphism (SNP)-based heritability, and checked genotype and subphenotype correlations. RESULTS: Two genome-wide significant loci, rs35087390 of HLA-DQA1 ( P =3.01×10 -39 ) on 6p21.32 and rs2417771 of PLEKHA5 on 12p12.3 ( P =2.14×10 -8 ), emerged from the analysis. HLA imputation using two reference panels suggested that HLA-DRB1*14 mainly drives the HLA risk association . HLA-DRB1 residue 60 belonging to pocket P10 was the key amino acid position. The SNP-based heritability estimates with and without the HLA locus were 20.43% and 10.35%, respectively. Different clinical subphenotypes (drug-related or tubulointerstitial nephritis and uveitis syndrome) seemed to share the same risk alleles. However, the HLA risk genotype was associated with disease severity and response rate to immunosuppressive therapy. CONCLUSIONS: We identified two candidate genome regions associated with susceptibility to ATIN. The findings suggest that a genetically conferred risk of immune dysregulation is involved in the pathogenesis of ATIN.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Zhou XJ, Su T, Xie J, et al. Genome-Wide Association Study in Acute Tubulointerstitial Nephritis. J Am Soc Nephrol. 2023. PMID: 36749126. doi:10.1681/ASN.0000000000000091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。